3
Registered trials
1
Recruiting
3
Unique sponsors
1
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Phase I:
2
Phase I (First in Human):
1
Phase I
2 trials-
EndedIovance Biotherapeutics Inc. CommercialIMP not specified
-
EndedInstitut Paoli Calmettes AcademicIMP not specified
Phase I (First in Human)
1 trial-
RecruitingAstraZeneca AB CommercialAZD3632
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | Commercial | 1 | Phase I | 0 |
| AstraZeneca AB | Commercial | 1 | Phase I (First in Human) | 1 |
| Institut Paoli Calmettes | Academic | 1 | Phase I | 0 |
New trials by year
2020
1
2025
2